Israel Englander Senti Biosciences, Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.36 - $0.66 $388 - $711
-1,078 Reduced 7.48%
13,337 $5,000
Q4 2023

Feb 14, 2024
BUY
$0.28 - $0.68 $4,036 - $9,802
14,415 New
14,415 $9,000
Q4 2022

Feb 14, 2023
SELL
$1.25 - $65.2 $26,243 - $1.37 Million
-20,995 Reduced 48.06%
22,694 $32,000
Q3 2022

Nov 14, 2022
BUY
$1.33 - $21.7 $9,931 - $162,033
7,467 Added 20.61%
43,689 $95,000

Others Institutions Holding SNTI

# of Institutions
18
Shares Held
8.79M
Call Options Held
0
Put Options Held
0
View Full List

About Senti Biosciences, Inc.

SNTI Quotes by TradingView
  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $95.8M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email